分子植物(英文版)(Molecular plant)(原:植物生理与分子生物学学报)

分子植物(英文版)(Molecular plant)(原:植物生理与分子生物学学报) 知网目次万方目次维普目次

  • CSCD
  • 科核
  • 高T1
基本信息
  • 主管单位:

    中国科学院

  • 主办单位:

    中科院上海生命科学研究院植物生理生态所、中国植物生理学会

  • 国际刊号:

    1674-2052;EISSN1752-9867

  • 国内刊号:

    31-2013/Q

  • 学科分类:

    生物科学

  • 字数:

    2000-44000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-月刊

  • 特殊属性:

    第一批认定学术期刊,外文期刊

联系信息
  • 电话:

    021-54922858(官网电话)

  • 邮箱:

    mplant@sibs.ac.cnstaff-mplant@sibs.ac.cn(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,万方目次,维普目次

  • 级别:

    CSCD,科核,高T1

期刊简介

《分子植物(英文版)(Molecular plant)(原:植物生理与分子生物学学报)》期刊已被查看:

更新频次

高频栏目:

Spotlights-100%-期平均发文量4篇
Research articles-100%-期平均发文量5篇

中频栏目:

Correspondences-50.0%-期平均发文量2篇
Resource article-50.0%-期平均发文量1篇
Correction-33.3%-期平均发文量1篇
Correspondence-33.3%-期平均发文量1篇

低频栏目:

Editorials-16.7%-期平均发文量2篇
Review articles-16.7%-期平均发文量7篇
Review article-16.7%-期平均发文量1篇
Comment-16.7%-期平均发文量1篇
Editor's Highlight-16.7%-期平均发文量1篇
Research repor-16.7%-期平均发文量1篇

单位占比

其他-100.0%

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、刊内网址:(202403期)

http://www.cell.com/molecular-plant/

http://www.molplant.org(刊内公布,但打不开)

3、投稿系统:

https://www.editorialmanager.com/molecular-plant

4、官网邮箱:mplant@sibs.ac.cn

staff-mplant@sibs.ac.cn

5、官网电话:021-54922858

6、出刊日期:月刊,每月月初出版。

2024年5月9日星期四

《分子植物(英文版)》作者须知

【官网信息】

Information for authors

Established in 2008, Molecular Plant is dedicated to serving the global plant science community by publishing novel and exciting findings with high significance. The journal focuses broadly on cellular biology, physiology, biochemistry, molecular biology, genetics, development, plant-microbe interaction, genomics, bioinformatics, and molecular evolution. All contents published in Molecular Plant are freely available starting 12 months after publication.

Editorial process

Molecular Plant uses single-blind peer review. All submissions are initially evaluated by professional scientific editors in consultation with editorial board members when necessary. Submissions that are deemed not appropriate for publication in Molecular Plant after initial evaluations will be returned to authors without external reviews, typically within 7 working days, so that submission elsewhere will not be delayed. Manuscripts selected for external reviews will be typically handled by professional scientific editors and evaluated by three reviewers for each research manuscript. Editors will make every effort to ensure timely reviews and generate an editorial decision typically within 4 to 5 weeks of manuscript receipt.

If publication is contingent on a revision, the handling editor will evaluate the reviewers' comments and provide specific guidance on the revision. In general, 1 month will be given to manuscripts that require minor revisions and 3 months for those that require major revisions. Molecular Plant allows only two rounds of submissions for any manuscripts that require revisions.

The same editor and reviewers who reviewed the previous version will typically evaluate resubmitted versions of previously rejected manuscripts. However, in some cases, the editor may find it appropriate or necessary to recruit new reviewers. There is no time limit for resubmission, but any conceptual advance and significance are evaluated based on the literature available on the day of the final decision, not the day of submission.

Typically, accepted papers will be published online within 5–10 days and in print within 3 months after acceptance. Any major changes after acceptance are subject to review and may delay publication.

Presubmission inquiries

Molecular Plant welcomes authors to send presubmission inquiries regarding suitability of their manuscripts. For research or review articles, such inquiries should include a significance statement of the research or review paper, plus a title page containing author information, abstract, and key figures (with legends) of the manuscript. For other short-format papers, presubmission inquiries should include the full paper. All presubmission inquiries should be sent to mplant@sibs.ac.cn.

Status inquiries

Once submitted, the status of a manuscript will be indicated as “Under review” soon after the initial format check until a decision is made on this paper. All inquiries on review status of a submission should be directed to staff-mplant@sibs.ac.cn.

Transfer of papers between Cell Press journals and Molecular Plant

Although each journal published by Cell Press is editorially independent, we have been using Editorial Manager, a manuscript tracking system that allows authors to transfer manuscripts along with any review comments they may have between Molecular Plant and Plant Communications. Should you have any questions about the suitability of your paper for transfer, please contact the e-mail address of the receiving journal. Often, the receiving journal will be able to reach a decision based on the existing reviews. Occasionally, the receiving journal may seek comments from additional reviewers. When you use Editorial Manager to transfer your paper, you will have a chance to edit your files before they are sent to the receiving journal. You can always submit your paper to one of the journals without mentioning the first review process. In this case, the manuscript will be evaluated as a regular new submission. If you are interested in transferring manuscripts from other Cell Press journals to Molecular Plant, please contact the journal directly at mplant@sibs.ac.cn.

……

更多详情:

https://www.cell.com/molecular-plant/authors

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。